<VariationArchive VariationID="472868" VariationName="NM_022489.4(INF2):c.490_498del (p.Ala164_Asp166del)" VariationType="Deletion" Accession="VCV000472868" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-05" DateCreated="2018-05-26" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="464026" VariationID="472868">
      <GeneList>
        <Gene Symbol="INF2" FullName="inverted formin 2" GeneID="64423" HGNC_ID="HGNC:23791" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q32.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="104689618" stop="104722535" display_start="104689618" display_stop="104722535" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="105155942" stop="105185946" display_start="105155942" display_stop="105185946" Strand="+" />
          </Location>
          <OMIM>610982</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_022489.4(INF2):c.490_498del (p.Ala164_Asp166del)</Name>
      <CanonicalSPDI>NC_000014.9:104703194:CCCTGGACGCCCTGGAC:CCCTGGAC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q32.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="104703195" stop="104703203" display_start="104703195" display_stop="104703203" variantLength="9" positionVCF="104703194" referenceAlleleVCF="ACCCTGGACG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="105169532" stop="105169540" display_start="105169532" display_stop="105169540" variantLength="9" positionVCF="105169531" referenceAlleleVCF="ACCCTGGACG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.105169540_105169548del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.105169540_105169548del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.104703203_104703211del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.104703203_104703211del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027684.1" sequenceAccession="NG_027684" sequenceVersion="1" change="g.18598_18606del">
            <Expression>NG_027684.1:g.18598_18606del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031714.4" sequenceAccession="NM_001031714" sequenceVersion="4" change="c.490_498del">
            <Expression>NM_001031714.4:c.490_498del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001026884.3" sequenceAccession="NP_001026884" sequenceVersion="3" change="p.Ala164_Asp166del">
            <Expression>NP_001026884.3:p.Ala164_Asp166del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022489.4" sequenceAccession="NM_022489" sequenceVersion="4" change="c.490_498del" MANESelect="true">
            <Expression>NM_022489.4:c.490_498del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_071934.3" sequenceAccession="NP_071934" sequenceVersion="3" change="p.Ala164_Asp166del">
            <Expression>NP_071934.3:p.Ala164_Asp166del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032714.3" sequenceAccession="NM_032714" sequenceVersion="3" change="c.490_498del">
            <Expression>NM_032714.3:c.490_498del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116103.1" sequenceAccession="NP_116103" sequenceVersion="1" change="p.Ala164_Asp166del">
            <Expression>NP_116103.1:p.Ala164_Asp166del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658658276" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="610982.0011" DB="OMIM" />
        <XRef Type="rs" ID="1555373599" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022489.4(INF2):c.490_498del (p.Ala164_Asp166del) AND multiple conditions" Accession="RCV000543208" Version="7">
        <ClassifiedConditionList TraitSetID="12945">
          <ClassifiedCondition DB="MedGen" ID="C4302667">Charcot-Marie-Tooth disease dominant intermediate E</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2750475">Focal segmental glomerulosclerosis 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_022489.4(INF2):c.490_498del (p.Ala164_Asp166del) AND Charcot-Marie-Tooth disease dominant intermediate E" Accession="RCV002286575" Version="1">
        <ClassifiedConditionList TraitSetID="7881">
          <ClassifiedCondition DB="MedGen" ID="C4302667">Charcot-Marie-Tooth disease dominant intermediate E</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-12-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-06" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-05-26" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22187985</ID>
        </Citation>
        <DescriptionHistory Dated="2018-05-26">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="12945" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6736" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Focal segmental glomerulosclerosis 5</ElementValue>
                <XRef ID="Focal+segmental+glomerulosclerosis+5/8439" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013191" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FSGS5</ElementValue>
                <XRef Type="MIM" ID="613237" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15636" />
                <XRef ID="15636" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="656" DB="Orphanet" />
              <XRef ID="C2750475" DB="MedGen" />
              <XRef ID="MONDO:0013191" DB="MONDO" />
              <XRef Type="MIM" ID="613237" DB="OMIM" />
            </Trait>
            <Trait ID="16808" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease dominant intermediate E</ElementValue>
                <XRef ID="MONDO:0013758" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS</ElementValue>
                <XRef Type="MIM" ID="614455" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMTDIE</ElementValue>
                <XRef Type="MIM" ID="614455" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant intermediate Charcot-Marie-Tooth disease E with focal segmental glomerulonephritis is characterized by the neurologic features of CMT, including distal muscle weakness and atrophy and distal sensory loss, and the features of FSGS, including proteinuria, progression to end-stage renal disease, and a characteristic histologic pattern on renal biopsy (summary by Boyer et al., 2011).
Isolated focal segmental glomerulosclerosis-5 (FSGS5; 613237) is also caused by heterozygous mutation in the INF2 gene.
For a discussion of genetic heterogeneity of CMTDI, see 606482.</Attribute>
                <XRef Type="MIM" ID="614455" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12011" />
                <XRef ID="12011" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="93114" DB="Orphanet" />
              <XRef ID="C4302667" DB="MedGen" />
              <XRef ID="MONDO:0013758" DB="MONDO" />
              <XRef Type="MIM" ID="614455" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7881" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16808" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease dominant intermediate E</ElementValue>
                <XRef ID="MONDO:0013758" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS</ElementValue>
                <XRef Type="MIM" ID="614455" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMTDIE</ElementValue>
                <XRef Type="MIM" ID="614455" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant intermediate Charcot-Marie-Tooth disease E with focal segmental glomerulonephritis is characterized by the neurologic features of CMT, including distal muscle weakness and atrophy and distal sensory loss, and the features of FSGS, including proteinuria, progression to end-stage renal disease, and a characteristic histologic pattern on renal biopsy (summary by Boyer et al., 2011).
Isolated focal segmental glomerulosclerosis-5 (FSGS5; 613237) is also caused by heterozygous mutation in the INF2 gene.
For a discussion of genetic heterogeneity of CMTDI, see 606482.</Attribute>
                <XRef Type="MIM" ID="614455" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12011" />
                <XRef ID="12011" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="93114" DB="Orphanet" />
              <XRef ID="C4302667" DB="MedGen" />
              <XRef ID="MONDO:0013758" DB="MONDO" />
              <XRef Type="MIM" ID="614455" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50401" SubmissionDate="2013-02-26" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="610982.0011_CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E" title="INF2, 9-BP DEL, NT490_CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E" />
        <ClinVarAccession Accession="SCV000045145" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-12-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of 2 Caucasian families with CMTDIE (614455), Boyer et al. (2011) identified a heterozygous 9-bp deletion (490_498del) in exon 3 of the INF2 gene, resulting in an in-frame deletion of 3 conserved residues (ala164-asp166). The mutation was not found in 670 control chromosomes.</Attribute>
              <Citation>
                <ID Source="PubMed">22187985</ID>
              </Citation>
              <XRef DB="OMIM" ID="614455" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="INF2" />
          </GeneList>
          <Name>INF2, 9-BP DEL, NT490</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">9-BP DEL, NT490</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610982.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1250312" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="2361027|MedGen:C3280845;C2750475" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000652132" DateUpdated="2024-02-28" DateCreated="2017-12-26" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22187985</ID>
          </Citation>
          <Comment>This variant has been observed in individual(s) with Charcot-Marie-Tooth (CMT) and focal segmental glomerulosclerosis (PMID: 22187985; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This variant, c.490_498del, results in the deletion of 3 amino acid(s) of the INF2 protein (p.Ala164_Asp166del), but otherwise preserves the integrity of the reading frame. ClinVar contains an entry for this variant (Variation ID: 472868). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="INF2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.105169532_105169540del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280845" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2750475" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1250312" TraitType="Disease" MappingType="XRef" MappingValue="C2750475" MappingRef="MedGen">
        <MedGen CUI="C2750475" Name="Focal segmental glomerulosclerosis 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1250312" TraitType="Disease" MappingType="XRef" MappingValue="C3280845" MappingRef="MedGen">
        <MedGen CUI="C4302667" Name="Charcot-Marie-Tooth disease dominant intermediate E" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50401" TraitType="Disease" MappingType="Name" MappingValue="CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E" MappingRef="Preferred">
        <MedGen CUI="C4302667" Name="Charcot-Marie-Tooth disease dominant intermediate E" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

